Kalpit Patel
Stock Analyst at B. Riley Securities
(1.95)
# 3,181
Out of 5,090 analysts
70
Total ratings
41.67%
Success rate
-8.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PDSB PDS Biotechnology | Maintains: Buy | $5 → $3 | $0.87 | +244.83% | 6 | Nov 25, 2025 | |
| ORIC ORIC Pharmaceuticals | Initiates: Peer Perform | n/a | $11.00 | - | 1 | Nov 18, 2025 | |
| CORT Corcept Therapeutics | Initiates: Peer Perform | n/a | $86.11 | - | 1 | Nov 18, 2025 | |
| JANX Janux Therapeutics | Initiates: Peer Perform | n/a | $16.51 | - | 1 | Nov 18, 2025 | |
| TNGX Tango Therapeutics | Initiates: Peer Perform | n/a | $9.63 | - | 1 | Nov 18, 2025 | |
| ACLX Arcellx | Initiates: Peer Perform | n/a | $69.56 | - | 1 | Nov 18, 2025 | |
| SMMT Summit Therapeutics | Initiates: Peer Perform | n/a | $18.31 | - | 1 | Nov 18, 2025 | |
| SRRK Scholar Rock Holding | Initiates: Outperform | $42 | $45.02 | -6.71% | 1 | Nov 18, 2025 | |
| SLNO Soleno Therapeutics | Initiates: Outperform | $75 | $51.37 | +46.00% | 1 | Nov 18, 2025 | |
| RVMD Revolution Medicines | Initiates: Outperform | $75 | $79.64 | -5.83% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $110 | $105.63 | +4.14% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $12 | $7.93 | +51.32% | 6 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $38 → $60 | $66.62 | -9.94% | 5 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $14 | $7.07 | +98.02% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $24.69 | +49.86% | 1 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $24 | $48.92 | -50.94% | 6 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $3.5 | $1.31 | +167.18% | 4 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $10.36 | -13.13% | 4 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $4.36 | +129.36% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $40 | $10.24 | +290.63% | 2 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.67 | +79.64% | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $25 → $20 | $32.02 | -37.54% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $90 → $30 | $3.98 | +653.77% | 1 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $36 | $20.32 | +77.17% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $90 | $1.79 | +4,927.93% | 3 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $1.43 | +1,158.74% | 2 | Sep 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $2.15 | +132.56% | 2 | Jul 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $11.50 | +769.57% | 1 | Jan 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $75 | $19.93 | +276.32% | 2 | Sep 3, 2021 |
PDS Biotechnology
Nov 25, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.87
Upside: +244.83%
ORIC Pharmaceuticals
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $11.00
Upside: -
Corcept Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $86.11
Upside: -
Janux Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $16.51
Upside: -
Tango Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $9.63
Upside: -
Arcellx
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $69.56
Upside: -
Summit Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $18.31
Upside: -
Scholar Rock Holding
Nov 18, 2025
Initiates: Outperform
Price Target: $42
Current: $45.02
Upside: -6.71%
Soleno Therapeutics
Nov 18, 2025
Initiates: Outperform
Price Target: $75
Current: $51.37
Upside: +46.00%
Revolution Medicines
Nov 18, 2025
Initiates: Outperform
Price Target: $75
Current: $79.64
Upside: -5.83%
Nov 18, 2025
Initiates: Outperform
Price Target: $110
Current: $105.63
Upside: +4.14%
Jul 30, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $7.93
Upside: +51.32%
Jun 3, 2025
Upgrades: Buy
Price Target: $38 → $60
Current: $66.62
Upside: -9.94%
May 2, 2025
Maintains: Neutral
Price Target: $17 → $14
Current: $7.07
Upside: +98.02%
Mar 20, 2025
Initiates: Buy
Price Target: $37
Current: $24.69
Upside: +49.86%
Mar 5, 2025
Maintains: Neutral
Price Target: $20 → $24
Current: $48.92
Upside: -50.94%
Feb 18, 2025
Maintains: Buy
Price Target: $5.5 → $3.5
Current: $1.31
Upside: +167.18%
Jan 31, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $10.36
Upside: -13.13%
Jan 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.36
Upside: +129.36%
Sep 20, 2024
Maintains: Buy
Price Target: $85 → $40
Current: $10.24
Upside: +290.63%
Jun 18, 2024
Maintains: Buy
Price Target: $9 → $3
Current: $1.67
Upside: +79.64%
May 9, 2024
Downgrades: Neutral
Price Target: $25 → $20
Current: $32.02
Upside: -37.54%
Dec 12, 2023
Downgrades: Neutral
Price Target: $90 → $30
Current: $3.98
Upside: +653.77%
Jul 25, 2023
Maintains: Buy
Price Target: $34 → $36
Current: $20.32
Upside: +77.17%
Nov 11, 2022
Downgrades: Neutral
Price Target: $270 → $90
Current: $1.79
Upside: +4,927.93%
Sep 22, 2022
Maintains: Buy
Price Target: $21 → $18
Current: $1.43
Upside: +1,158.74%
Jul 19, 2022
Maintains: Buy
Price Target: $6 → $5
Current: $2.15
Upside: +132.56%
Jan 24, 2022
Maintains: Buy
Price Target: $240 → $100
Current: $11.50
Upside: +769.57%
Sep 3, 2021
Downgrades: Neutral
Price Target: $75
Current: $19.93
Upside: +276.32%